Aelis Farma SA
No trades
−0.600 EUR
−7.46 M EUR
2.68 M EUR
4.16 M
About Aelis Farma SA
Sector
Industry
CEO
Pier Vincenzo Piazza
Website
Headquarters
Bordeaux
Founded
2013
IPO date
Feb 18, 2022
Identifiers
2
ISIN FR0014007ZB4
Aelis Farma SA is a biopharmaceutical company. It engages in the business of researching and developing pharmaceutical products. The company was founded by Valérie Scappaticci and Pier Vincenzo Piazza on October 7, 2013 and is headquartered in Bordeaux, France.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of AELIS is 1.200 EUR — it has decreased by −5.51% in the past 24 hours. Watch Aelis Farma SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange Aelis Farma SA stocks are traded under the ticker AELIS.
AELIS stock has fallen by −14.89% compared to the previous week, the month change is a −11.11% fall, over the last year Aelis Farma SA has showed a −22.58% decrease.
AELIS reached its all-time high on Feb 18, 2022 with the price of 14.480 EUR, and its all-time low was 0.670 EUR and was reached on Jul 23, 2025. View more price dynamics on AELIS chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
AELIS stock is 10.34% volatile and has beta coefficient of −0.66. Track Aelis Farma SA stock price on the chart and check out the list of the most volatile stocks — is Aelis Farma SA there?
Today Aelis Farma SA has the market capitalization of 17.41 M, it has decreased by −7.19% over the last week.
Yes, you can track Aelis Farma SA financials in yearly and quarterly reports right on TradingView.
AELIS net income for the last half-year is −4.32 M EUR, while the previous report showed −3.87 M EUR of net income which accounts for 0.00% change. Track more Aelis Farma SA financial stats to get the full picture.
No, AELIS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 7, 2026, the company has 28 employees. See our rating of the largest employees — is Aelis Farma SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Aelis Farma SA EBITDA is −9.83 M EUR, and current EBITDA margin is −386.52%. See more stats in Aelis Farma SA financial statements.
Like other stocks, AELIS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aelis Farma SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aelis Farma SA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aelis Farma SA stock shows the strong sell signal. See more of Aelis Farma SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.